World News: 09:00 GMT Wednesday 12th June 2019. [INNATE PHARMA via Globe Newswire via SPi World News]
Innate Pharma SA the- Euronext Paris FR0010331421 IPH today announced that the of the TELLOMAK Phase II trial and new preclinical data supporting the potential of in peripheral T-cell lymphoma PTCL as well...
Globe Newswire: 09:00 GMT Wednesday 12th June 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.